Content of brain aluminum is not elevated in Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 10, Issue 3, 1996, Pages 171-174

  Bjertness, E ^a   Candy, J M ^d   Torvik, A ^b   Ince, P ^d   McArthur, F ^d   Taylor, G A ^d   Johansen, S W ^c   Alexander, J ^c   Gronnesby, J K ^a   Bakketeig, L S ^c   Edwardson, J A ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Aluminum; Alzheimer disease; Dementia; Epidemiology; Graphite furnace atomic absorption spectrometry; Hypothesis; Neuropathology

Indexed keywords

ALUMINUM;

ADULT; ALZHEIMER DISEASE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN LEVEL; CONTROLLED STUDY; DENSITY; FEMALE; FEMUR HEAD; FRONTAL CORTEX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SENILE PLAQUE; TEMPORAL CORTEX;

EID: 9544243820     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199601030-00006     Document Type: Article

References (19)

1. Crapper DR, Krishnan SS, Dalton AJ. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration, Science 1973;180:511-3.
2. Crapper DR, Krishnan SS, Quittkat S. Aluminum, neurofibrillary degeneration and Alzheimer's disease. Brain 1976;99:67-80.
3. Hughes CP, Berg L, Danzinger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-72.
4. Engedal K, Haugen PK. The prevalence of dementia in a sample of elderly Norwegians. Int J Geriatr Psychiatry 1993;8:565-70.
5. Ince P, McArthur FK, Bjertness E, Torvik A, Candy JM, Edwardson JA. Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease and vascular lesions. Dementia 1995;6:162-8.
6. Jacobs RW, Duong T, Jones RE, Trapp GA, Scheibel AB. A re-examination of aluminum in Alzheimer's disease: analysis by energy dispersive x-ray μprobe and flameless atomic absorption spectrophotometry. Can J Neurol Sci 1989;16:498-503.
7. Johansen SW, Andruchow E, Hongve D, Alexander J, Becher G, Bjertness E. Determination of aluminum in bone and liver. 13th Nordic Atomic Spectroscopy and Trace Element Conference, Norway, 1992.
8. Krishnan SS, Harrison JE, Crapper McLachlan DR. Origin and resolution of the aluminum controversy concerning Alzheimer's neurofibrillary degeneration. Biol Trace Element Res 1987;13:35-42.
9. Markesbery WR, Ehmann WD, Hossain TIM, Alauddin M, Goodin DT. Instrumental neutron activation analysis of brain aluminum in Alzheimer's disease and aging. Ann Neurol 1981;10:511-6.
10. McDermott JR, Smith AI, Iqbal K, Wisniewski HM. Brain aluminum in aging and Alzheimer's disease. Neurology 1979;29:809-14.
11. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
12. Morris CM, Candy JM, Oakley AE, et al. Comparison of regional distribution of transferrin receptors and aluminum in the forebrain of chronic renal dialysis patients. J Neurol Sci 1989;94:295-306.
13. Parkinson IS, Ward MK, Kerr DN. A method for the routine determination of aluminum in serum and water by flameless atomic absorption spectrometry. Clin Chim Acta 1982;125:125-33.
14. Taylor GA, Ferrier IN, McLoughlin IJ, et al. Gastrointestinal absorption of aluminum and Alzheimer's disease: response to aluminum citrate. Age Aging 1992;21:81-90.
15. Trapp GA, Miner GD, Zimmermann RL, Mastri AR, Heston LL. Aluminum levels in brain in Alzheimer's disease. Biol Psychiatry 1978;13:709-18.
16. Traub RD, Rains TC, Garruto RM, Gajdusek DC, Gibbs CJ. Brain destruction alone does not elevate brain aluminum. Neurology 1981;31:986-90.
17. Ward NI, Mason JA. Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease. J Radioanal Nucl Chem 1987;113:515-26.
18. Xu N, Majidi V, Markesbery WR, Ehman WD. Brain aluminum in Alzheimer's disease using an improved GFAAS method. Neurotoxicology 1992;13:735-44.
19. Yoshimasu F, Masayuki M, YoshiroY, et al. Studies on amyotrophic lateral sclerosis by neutron activation analysis - 2. Comparative study of analytical results on Guam PD, Japanese ALS and Alzheimer's disease cases. Folia Psychiatr Neurol Jpn 1980;34:75-82.